Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controls.

Journal of Alzheimer's disease : JAD - 1 Jan 2010

Sundelöf Johan, Sundström Johan, Hansson Oskar, Eriksdotter-Jönhagen Maria, Giedraitis Vilmantas, Larsson Anders, Degerman-Gunnarsson Malin, Ingelsson Martin, Minthon Lennart, Blennow Kaj, Kilander Lena, Basun Hans, Lannfelt Lars

Abstract excerpt

Cathepsin B is suggested to be involved in amyloid-β (Aβ) processing and Alzheimer's disease (AD). Studies of cathepsin B levels in plasma and cerebrospinal fluid (CSF) have not been previously performed. We examined cathepsin B levels in plasma and CSF samples in persons with AD, mild cognitive impairment (MCI), and healthy controls in order to test the hypothesis that cathepsin B levels can discriminate persons...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Albumins
Share to Analysis of Variance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Cathepsin B

Share to Cognition Disorders

Share to Cystatin C

Share to Enzyme-Linked Immunosorbent Assay

Share to tau Proteins

Source

Identifiers

PMID: 20930303
DOI: 10.3233/JAD-2010-101023

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controls.PMID 20930303Read ↗

Serum Cathepsin S Levels Do Not Show Alterations in Different Clinical, Neuropathological, or Genetic Subtypes of Frontotemporal Dementia Patients nor in Comparison to Healthy Control Individuals.Semantic proximity Read ↗

Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls.Semantic proximity Read ↗

The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease.Semantic proximity Read ↗

Plasma Small Extracellular Vesicle Cathepsin D Dysregulation in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration.Semantic proximity Read ↗

Genetic Insights Into the Role of Cathepsins in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis: Evidence From Mendelian Randomization Study.Semantic proximity Read ↗

Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias.Semantic proximity Read ↗

Autophagy Markers Are Altered in Alzheimer’s Disease, Dementia with Lewy Bodies and Frontotemporal DementiaSemantic proximity Read ↗

Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease.Semantic proximity Read ↗

The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in developmentSemantic proximity Read ↗

Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer DiseaseSemantic proximity Read ↗

YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s DiseaseSemantic proximity Read ↗

CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.